NCT04382911View on ClinicalTrials.gov

Evaluation of Endometriosis With 18F-fluoroestradiol PET / MRI

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 7, 2020

Primary Completion Date

July 11, 2022

Study Completion Date

July 11, 2022

Conditions
Endometriosis
Interventions
DRUG

18F-fluoroestradiol

Patients will receive the FES tracer during a PET/MRI scan

Trial Locations (1)

27599

UNC Hospitals, Chapel Hill

All Listed Sponsors
collaborator

North Carolina Translational and Clinical Sciences Institute

OTHER

lead

University of North Carolina, Chapel Hill

OTHER

NCT04382911 - Evaluation of Endometriosis With 18F-fluoroestradiol PET / MRI | Biotech Hunter | Biotech Hunter